Higher Busulfan Dose Intensity Does Not Improve Outcomes of...

Biology of Blood and Marrow Transplantation 2011 Vol. 17; Iss. 2-supp-S

Higher Busulfan Dose Intensity Does Not Improve Outcomes of Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (AHCT) Following Fludarabine/Busulfan/Atg (FBA)-Based Reduced Toxicity Conditioning (RTC)

M. Hamadani, M. Craig, J. Abraham, W. Tse, A. Cumpston, L.F. Gibson, S.C. Remick, S. Leadmon, P. Elder, C. Hofmeister, S. Penza, L. Andritsos, W. Blum, D.M. Benson Jr., S.M. Devine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2010.12.454
File:
PDF, 61 KB
english, 2011
Conversion to is in progress
Conversion to is failed